130 related articles for article (PubMed ID: 9924916)
1. Riding on a carousel with IFN-alpha and TNF-alpha.
Zierhut M
Ocul Immunol Inflamm; 1998 Dec; 6(4):209-10. PubMed ID: 9924916
[No Abstract] [Full Text] [Related]
2. Anti-TNFalpha therapy modulates the phenotype of peripheral blood CD4+ T cells in patients with posterior segment intraocular inflammation.
Greiner K; Murphy CC; Willermain F; Duncan L; Plskova J; Hale G; Isaacs JD; Forrester JV; Dick AD
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):170-6. PubMed ID: 14691170
[TBL] [Abstract][Full Text] [Related]
3. Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis.
Mizuguchi J; Takeuchi M; Usui M
Arch Immunol Ther Exp (Warsz); 2002; 50(4):243-54. PubMed ID: 12371620
[TBL] [Abstract][Full Text] [Related]
4. Th1 and Th2 cells in autoimmunity.
Druet P; Sheela R; Pelletier L
Clin Exp Immunol; 1995 Jul; 101 Suppl 1(Suppl 1):9-12. PubMed ID: 7606862
[No Abstract] [Full Text] [Related]
5. Effect of type I interferon on experimental autoimmune uveoretinitis in rats.
Okada AA; Keino H; Fukai T; Sakai J; Usui M; Mizuguchi J
Ocul Immunol Inflamm; 1998 Dec; 6(4):215-26. PubMed ID: 9924918
[TBL] [Abstract][Full Text] [Related]
6. Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis.
Caspi RR
Int Rev Immunol; 2002; 21(2-3):197-208. PubMed ID: 12424843
[TBL] [Abstract][Full Text] [Related]
7. IL-10 has a protective role in experimental autoimmune uveoretinitis.
Rizzo LV; Xu H; Chan CC; Wiggert B; Caspi RR
Int Immunol; 1998 Jun; 10(6):807-14. PubMed ID: 9678762
[TBL] [Abstract][Full Text] [Related]
8. [Translational research with experimental autoimmune uveoretinitis (EAU)].
Usui M
Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):137-58; discussion 159. PubMed ID: 17402560
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis.
Dick AD; Duncan L; Hale G; Waldmann H; Isaacs J
J Autoimmun; 1998 Jun; 11(3):255-64. PubMed ID: 9693974
[TBL] [Abstract][Full Text] [Related]
10. Adoptive transfer of experimental autoimmune uveoretinitis in HgCl2 injected rats.
Saoudi A; Bellon B; de Kozak Y; Druet P
Curr Eye Res; 1992; 11 Suppl():101-5. PubMed ID: 1424735
[TBL] [Abstract][Full Text] [Related]
11. The role of costimulatory molecules B7-1 and B7-2 in mice with experimental autoimmune uveoretinitis.
Fukai T; Okada AA; Sakai J; Kezuka T; Keino H; Usui M; Yagita H; Okumura K; Mizuguchi J
Graefes Arch Clin Exp Ophthalmol; 1999 Nov; 237(11):928-33. PubMed ID: 10541904
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin aggravates experimental autoimmune uveoretinitis in mice.
Kitamura M; Iwabuchi K; Kitaichi N; Kon S; Kitamei H; Namba K; Yoshida K; Denhardt DT; Rittling SR; Ohno S; Uede T; Onoé K
J Immunol; 2007 May; 178(10):6567-72. PubMed ID: 17475887
[TBL] [Abstract][Full Text] [Related]
13. Recruitment of IFN-gamma-producing (Th1-like) cells into the inflamed retina in vivo is preferentially regulated by P-selectin glycoprotein ligand 1:P/E-selectin interactions.
Xu H; Manivannan A; Jiang HR; Liversidge J; Sharp PF; Forrester JV; Crane IJ
J Immunol; 2004 Mar; 172(5):3215-24. PubMed ID: 14978129
[TBL] [Abstract][Full Text] [Related]
14. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis.
Xu H; Rizzo LV; Silver PB; Caspi RR
Cell Immunol; 1997 May; 178(1):69-78. PubMed ID: 9184700
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina.
Dick AD; McMenamin PG; Körner H; Scallon BJ; Ghrayeb J; Forrester JV; Sedgwick JD
Eur J Immunol; 1996 May; 26(5):1018-25. PubMed ID: 8647162
[TBL] [Abstract][Full Text] [Related]
16. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?
Gómez D; Correa PA; Gómez LM; Cadena J; Molina JF; Anaya JM
Semin Arthritis Rheum; 2004 Jun; 33(6):404-13. PubMed ID: 15190525
[TBL] [Abstract][Full Text] [Related]
17. Disruption of CD40/CD40-ligand interactions in a retinal autoimmunity model results in protection without tolerance.
Bagenstose LM; Agarwal RK; Silver PB; Harlan DM; Hoffmann SC; Kampen RL; Chan CC; Caspi RR
J Immunol; 2005 Jul; 175(1):124-30. PubMed ID: 15972638
[TBL] [Abstract][Full Text] [Related]
18. Cytokines in immunotherapy of experimental uveitis.
de Kozak Y; Verwaerde C
Int Rev Immunol; 2002; 21(2-3):231-53. PubMed ID: 12424845
[TBL] [Abstract][Full Text] [Related]
19. Propolis modulates NOS2/arginase-1 pathway in tropomyosin-induced experimental autoimmune uveitis.
Touri K; Belguendouz H; Medjeber O; Djeraba Z; Lahmar K; Touil-Boukoffa C
Inflammopharmacology; 2018 Oct; 26(5):1293-1303. PubMed ID: 29752572
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy suppresses both Th1 and Th2 responses by allergen stimulation, but suppression of the Th2 response is a more important mechanism related to the clinical efficacy of immunotherapy for perennial allergic rhinitis.
Tanaka A; Ohashi Y; Kakinoki Y; Nakai Y
Scand J Immunol; 1998 Aug; 48(2):201-11. PubMed ID: 9716113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
